Severe COVID-19 in Alzheimer's disease: APOE4's fault again?

Xiong, Nian; Schiller, Martin R; Li, Jingwen; Chen, Xiaowu; Lin, Zhicheng

Xiong, Nian; Schiller, Martin R; Li, Jingwen; Chen, Xiaowu; Lin, Zhicheng.

Afiliación

Xiong N; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.
Schiller MR; Nevada Institute of Personalized Medicine and School of Life Sciences, University of Nevada Las Vegas, Las Vegas, NV, 89154, USA.
Li J; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.
Chen X; Department of Neurology, Shenzhen University General Hospital, Shenzhen, 518000, Guangdong, China.
Lin Z; Laboratory for Psychiatric Neurogenomics, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA. zhicheng_lin@hms.harvard.edu.

Alzheimers Res Ther ; 13(1): 111, 2021 Jun 12.

Article en En | MEDLINE | ID: mdl-34118974

Asunto(s)

Enfermedad de Alzheimer; COVID-19; Enfermedad de Alzheimer/genética; Apolipoproteína E4/genética; Humanos; Pandemias; SARS-CoV-2

Palabras clave

APOE4; Biomarker; COVID-19; Comorbidity; Coronavirus; Peripheral mechanisms

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Alzheimers Res Ther Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google